However, at 13 days after infusion of AAV-HD70, rats that had received AAV-shEGFP plus -HD70 exhibited a 10.1±2.1% impairment of the contralateral forepaw.
AAV-shHD2 plus -HD70-treated rats showed no impairment of the contralateral forepaw, exhibiting symmetrical use of forepaws in this task.